SPOKANE, Wash., Dec. 13 /PRNewswire/ -- HollisterStier Contract Manufacturing signed a manufacturing contract with GeneraMedix Inc. to develop a process for compounding and lyophilizing multiple generic drug products. GeneraMedix plans to utilize HollisterStier's Project Management System to meet targeted timelines and project specifications. Specific terms of the agreement were not disclosed.
(Logo: http://www.newscom.com/cgi-bin/prnh/20060228/SFTU141LOGO )
Anthony Bonanzino Ph.D., President and CEO of HollisterStier said, "Establishing this new arrangement with GeneraMedix is further evidence of HollisterStier's substantial technical competency. Merging the core competencies of each organization assures a rapid market introduction to meet this important patient need."
Ronald F. Quadrel, President and CEO of GeneraMedix Inc. said, "This new Agreement with HollisterStier Contract Manufacturing is another step in the development and buildup of our generic injectable product portfolio. We are very pleased to be working together with HollisterStier on these new products. We believe that HollisterStier has the team, the experience and the infrastructure to ensure the successful development and commercial supply of these products."
About HollisterStier
HollisterStier is a customer centric group of professionals dedicated to the contract manufacture of high quality sterile injectables for the global pharmaceutical and biopharmaceutical market. Our multidisciplinary teams provide custom solutions to customer specific project goals from development through commercialization. Based in Spokane, Washington, the company is committed to meeting customer expectations in all aspects of our business from quality manufacturing to regulatory support. For further information, visit www.hollisterstier.com .
About GeneraMedix Inc.
GeneraMedix Inc. is a pharmaceutical company offering high quality injectable generic products to the hospital and specialty markets. In addition to its products already marketed, GeneraMedix has a significant number of injectable products under development, as well as a number of products currently under FDA review. Headquartered in Liberty Corner, New Jersey, the company was founded in July of 2004. Additional information is available at the company's website at www.generamedix.com .
Photo: http://www.newscom.com/cgi-bin/prnh/20060228/SFTU141LOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comHollisterStier Contract ManufacturingCONTACT: Janelle Jovick of HollisterStier Contract Manufacturing,+1-509-482-0586, or jjovick@hollister-stier.com; or Dennis M. Potter ofGeneraMedix Inc., +1-908-504-1303, or dpotter@generamedix.com
